Quick Summary
Earnings beats and upgrades are driving sharp upside gaps
Weak guidance and regulatory risk are triggering heavy sell-offs
Tech, healthcare and AI-linked names dominate volatility
Gapping Up
Quince Therapeutics
+81.7%
Appointed LifeSci Capital to explore strategic alternatives and restructuring
Credo Technology
+14.5%
Issued preliminary Q3 revenue well above guidance
Ferrari
+10.8%
Q4 earnings beat and order book now stretches to end-2027
Entegris
+9.5%
Beat Q4 results and guided Q1 above consensus
Spotify Technology
+8.5%
Earnings beat, strong premium subscriber growth, and margin improvement
Datadog
+7.0%
Q4 beat and Q1 revenue guidance topped estimates
Oscar Health
+6.6%
Issued strong FY26 revenue and operating earnings outlook
Vistra Energy
+4.2%
Upgraded to Buy by Jefferies
Unity Software
+3.6%
Oppenheimer upgrade to Outperform
Astera Labs
+3.5%
Ahead of earnings and announced new AI design centre in Israel
Gapping Down
Upwork
-22.8%
Q1 guidance missed despite Q4 beat
S&P Global
-15.8%
2026 EPS guidance disappointed
Strategy
-4.8%
Price target cut by Cantor Fitzgerald
Coca-Cola
-4.1%
Q4 revenue miss and soft 2026 growth outlook
Hims & Hers Health
-3.8%
Legal and regulatory pressure over compounded semaglutide
ON Semiconductor
-3.7%
Revenue declined 11% YoY, weak Q1 EPS guidance
Salesforce
-3.3%
Reports of ~1,000 job cuts, including in AI-related teams
Market Takeaway
Earnings quality and forward guidance are everything
AI-linked winners are still rewarded, but misses are punished fast
Healthcare and crypto-exposed names face elevated regulatory and macro risk
This is a stock-picker’s market — volatility is being driven name by name, not index-wide.

Comments
Post a Comment